Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

WRBY vs EYE

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
WRBY
Warby Parker Inc.

Medical - Instruments & Supplies

HealthcareNYSE • US
Market Cap$3.34B
5Y Perf.-48.7%
EYE
National Vision Holdings, Inc.

Specialty Retail

Consumer CyclicalNASDAQ • US
Market Cap$1.81B
5Y Perf.-59.8%

WRBY vs EYE — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
WRBY logoWRBY
EYE logoEYE
IndustryMedical - Instruments & SuppliesSpecialty Retail
Market Cap$3.34B$1.81B
Revenue (TTM)$891M$1.99B
Net Income (TTM)$1M$30M
Gross Margin53.4%56.5%
Operating Margin-0.7%3.0%
Forward P/E56.7x32.6x
Total Debt$233M$695M
Cash & Equiv.$286M$39M

WRBY vs EYELong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

WRBY
EYE
StockSep 21May 26Return
Warby Parker Inc. (WRBY)10051.3-48.7%
National Vision Hol… (EYE)10040.2-59.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: WRBY vs EYE

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: EYE leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Warby Parker Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
WRBY
Warby Parker Inc.
The Growth Play

WRBY is the clearest fit if your priority is growth exposure and sleep-well-at-night.

  • Rev growth 13.0%, EPS growth 107.7%, 3Y rev CAGR 13.4%
  • Lower volatility, beta 2.22, Low D/E 63.4%, current ratio 2.35x
  • 13.0% revenue growth vs EYE's 9.0%
Best for: growth exposure and sleep-well-at-night
EYE
National Vision Holdings, Inc.
The Income Pick

EYE carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 2 yrs, beta 1.62
  • -18.0% 10Y total return vs WRBY's -50.1%
  • Beta 1.62, current ratio 0.55x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthWRBY logoWRBY13.0% revenue growth vs EYE's 9.0%
ValueEYE logoEYELower P/E (32.6x vs 56.7x)
Quality / MarginsEYE logoEYE1.5% margin vs WRBY's 0.2%
Stability / SafetyEYE logoEYEBeta 1.62 vs WRBY's 2.22
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)WRBY logoWRBY+68.3% vs EYE's +46.3%
Efficiency (ROA)EYE logoEYE1.5% ROA vs WRBY's 0.2%, ROIC 3.0% vs -1.3%

WRBY vs EYE — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

WRBYWarby Parker Inc.
FY 2025
Eyewear Products
92.8%$719M
Services And Other
7.2%$56M
EYENational Vision Holdings, Inc.
FY 2025
Product Sales
44.7%$1.6B
Eyeglasses And Sunglasses
35.3%$1.3B
Services And Plans
10.7%$383M
Contact Lenses
9.0%$324M
Accessories And Other
0.3%$11M

WRBY vs EYE — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLEYELAGGINGWRBY

Income & Cash Flow (Last 12 Months)

EYE leads this category, winning 5 of 6 comparable metrics.

EYE is the larger business by revenue, generating $2.0B annually — 2.2x WRBY's $891M. Profitability is closely matched — net margins range from 1.5% (EYE) to 0.2% (WRBY). On growth, EYE holds the edge at +15.1% YoY revenue growth, suggesting stronger near-term business momentum.

MetricWRBY logoWRBYWarby Parker Inc.EYE logoEYENational Vision H…
RevenueTrailing 12 months$891M$2.0B
EBITDAEarnings before interest/tax$32M$153M
Net IncomeAfter-tax profit$1M$30M
Free Cash FlowCash after capex$39M$73M
Gross MarginGross profit ÷ Revenue+53.4%+56.5%
Operating MarginEBIT ÷ Revenue-0.7%+3.0%
Net MarginNet income ÷ Revenue+0.2%+1.5%
FCF MarginFCF ÷ Revenue+4.4%+3.7%
Rev. Growth (YoY)Latest quarter vs prior year+8.3%+15.1%
EPS Growth (YoY)Latest quarter vs prior year+7.5%+111.3%
EYE leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

EYE leads this category, winning 6 of 6 comparable metrics.

At 61.7x trailing earnings, EYE trades at a 97% valuation discount to WRBY's 2076.3x P/E. On an enterprise value basis, EYE's 16.2x EV/EBITDA is more attractive than WRBY's 73.1x.

MetricWRBY logoWRBYWarby Parker Inc.EYE logoEYENational Vision H…
Market CapShares × price$3.3B$1.8B
Enterprise ValueMkt cap + debt − cash$3.3B$2.5B
Trailing P/EPrice ÷ TTM EPS2076.34x61.70x
Forward P/EPrice ÷ next-FY EPS est.56.75x32.60x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple73.08x16.20x
Price / SalesMarket cap ÷ Revenue3.83x0.91x
Price / BookPrice ÷ Book value/share9.25x2.12x
Price / FCFMarket cap ÷ FCF76.32x24.68x
EYE leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

EYE leads this category, winning 5 of 8 comparable metrics.

EYE delivers a 3.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $0 for WRBY. WRBY carries lower financial leverage with a 0.63x debt-to-equity ratio, signaling a more conservative balance sheet compared to EYE's 0.80x. On the Piotroski fundamental quality scale (0–9), EYE scores 7/9 vs WRBY's 6/9, reflecting strong financial health.

MetricWRBY logoWRBYWarby Parker Inc.EYE logoEYENational Vision H…
ROE (TTM)Return on equity+0.4%+3.5%
ROA (TTM)Return on assets+0.2%+1.5%
ROICReturn on invested capital-1.3%+3.0%
ROCEReturn on capital employed-1.0%+3.8%
Piotroski ScoreFundamental quality 0–967
Debt / EquityFinancial leverage0.63x0.80x
Net DebtTotal debt minus cash-$53M$656M
Cash & Equiv.Liquid assets$286M$39M
Total DebtShort + long-term debt$233M$695M
Interest CoverageEBIT ÷ Interest expense3.54x
EYE leads this category, winning 5 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

WRBY leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in WRBY five years ago would be worth $4,992 today (with dividends reinvested), compared to $4,462 for EYE. Over the past 12 months, WRBY leads with a +68.3% total return vs EYE's +46.3%. The 3-year compound annual growth rate (CAGR) favors WRBY at 31.0% vs EYE's 0.7% — a key indicator of consistent wealth creation.

MetricWRBY logoWRBYWarby Parker Inc.EYE logoEYENational Vision H…
YTD ReturnYear-to-date+20.2%-12.0%
1-Year ReturnPast 12 months+68.3%+46.3%
3-Year ReturnCumulative with dividends+125.0%+2.2%
5-Year ReturnCumulative with dividends-50.1%-55.4%
10-Year ReturnCumulative with dividends-50.1%-18.0%
CAGR (3Y)Annualised 3-year return+31.0%+0.7%
WRBY leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — WRBY and EYE each lead in 1 of 2 comparable metrics.

EYE is the less volatile stock with a 1.62 beta — it tends to amplify market swings less than WRBY's 2.22 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WRBY currently trades 87.7% from its 52-week high vs EYE's 76.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricWRBY logoWRBYWarby Parker Inc.EYE logoEYENational Vision H…
Beta (5Y)Sensitivity to S&P 5002.22x1.62x
52-Week HighHighest price in past year$31.00$30.02
52-Week LowLowest price in past year$14.96$14.38
% of 52W HighCurrent price vs 52-week peak+87.7%+76.0%
RSI (14)Momentum oscillator 0–10046.640.8
Avg Volume (50D)Average daily shares traded2.8M1.4M
Evenly matched — WRBY and EYE each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates WRBY as "Buy" and EYE as "Buy". Consensus price targets imply 54.2% upside for EYE (target: $35) vs 7.8% for WRBY (target: $29).

MetricWRBY logoWRBYWarby Parker Inc.EYE logoEYENational Vision H…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$29.33$35.20
# AnalystsCovering analysts1514
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises2
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%+0.2%
Insufficient data to determine a leader in this category.
Key Takeaway

EYE leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). WRBY leads in 1 (Total Returns). 1 tied.

Best OverallNational Vision Holdings, I… (EYE)Leads 3 of 6 categories
Loading custom metrics...

WRBY vs EYE: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is WRBY or EYE a better buy right now?

For growth investors, Warby Parker Inc.

(WRBY) is the stronger pick with 13. 0% revenue growth year-over-year, versus 9. 0% for National Vision Holdings, Inc. (EYE). National Vision Holdings, Inc. (EYE) offers the better valuation at 61. 7x trailing P/E (32. 6x forward), making it the more compelling value choice. Analysts rate Warby Parker Inc. (WRBY) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — WRBY or EYE?

On trailing P/E, National Vision Holdings, Inc.

(EYE) is the cheapest at 61. 7x versus Warby Parker Inc. at 2076. 3x. On forward P/E, National Vision Holdings, Inc. is actually cheaper at 32. 6x.

03

Which is the better long-term investment — WRBY or EYE?

Over the past 5 years, Warby Parker Inc.

(WRBY) delivered a total return of -50. 1%, compared to -55. 4% for National Vision Holdings, Inc. (EYE). Over 10 years, the gap is even starker: EYE returned -18. 0% versus WRBY's -50. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — WRBY or EYE?

By beta (market sensitivity over 5 years), National Vision Holdings, Inc.

(EYE) is the lower-risk stock at 1. 62β versus Warby Parker Inc. 's 2. 22β — meaning WRBY is approximately 37% more volatile than EYE relative to the S&P 500. On balance sheet safety, Warby Parker Inc. (WRBY) carries a lower debt/equity ratio of 63% versus 80% for National Vision Holdings, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — WRBY or EYE?

By revenue growth (latest reported year), Warby Parker Inc.

(WRBY) is pulling ahead at 13. 0% versus 9. 0% for National Vision Holdings, Inc. (EYE). On earnings-per-share growth, the picture is similar: National Vision Holdings, Inc. grew EPS 202. 8% year-over-year, compared to 107. 7% for Warby Parker Inc.. Over a 3-year CAGR, WRBY leads at 13. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — WRBY or EYE?

National Vision Holdings, Inc.

(EYE) is the more profitable company, earning 1. 5% net margin versus 0. 2% for Warby Parker Inc. — meaning it keeps 1. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EYE leads at 3. 1% versus -0. 6% for WRBY. At the gross margin level — before operating expenses — EYE leads at 54. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is WRBY or EYE more undervalued right now?

On forward earnings alone, National Vision Holdings, Inc.

(EYE) trades at 32. 6x forward P/E versus 56. 7x for Warby Parker Inc. — 24. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EYE: 54. 2% to $35. 20.

08

Which pays a better dividend — WRBY or EYE?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is WRBY or EYE better for a retirement portfolio?

For long-horizon retirement investors, National Vision Holdings, Inc.

(EYE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Warby Parker Inc. (WRBY) carries a higher beta of 2. 22 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (EYE: -18. 0%, WRBY: -50. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between WRBY and EYE?

These companies operate in different sectors (WRBY (Healthcare) and EYE (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

WRBY

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 32%
Run This Screen
Stocks Like

EYE

High-Growth Disruptor

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Gross Margin > 33%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform WRBY and EYE on the metrics below

Revenue Growth>
%
(WRBY: 8.3% · EYE: 15.1%)
P/E Ratio<
x
(WRBY: 2076.3x · EYE: 61.7x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.